PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27127879-0	2016	S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide.	Niclosamide	153-164	S100 calcium binding protein A4	Homo sapiens	0-6	
27127879-8	2016	Niclosamide, a reported inhibitor of S100A4, blocks expression and function of S100A4 with a reduction in proliferation, invasion and NF-kappaB-mediated MMP9 expression.	Niclosamide	0-11	S100 calcium binding protein A4	Homo sapiens	37-43	
27127879-8	2016	Niclosamide, a reported inhibitor of S100A4, blocks expression and function of S100A4 with a reduction in proliferation, invasion and NF-kappaB-mediated MMP9 expression.	Niclosamide	0-11	S100 calcium binding protein A4	Homo sapiens	79-85